Point72 Hong Kong LTD Meridian Bioscience Inc Transaction History

Point72 Hong Kong LTD

  • $1.35 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$15.73 - $21.66 $28,502 - $39,247
-1,812 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$13.54 - $26.41 $24,534 - $47,854
1,812 New
1,812 $31,000
Q2 2018

Aug 14, 2018
SELL
$13.8 - $16.8 $27 - $33
-2 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$13.8 - $16.2 $27 - $32
2 New
2 $0

Others Institutions Holding VIVO

# of Institutions
10
Shares Held
113K
Call Options Held
0
Put Options Held
0
View Full List

About MERIDIAN BIOSCIENCE INC

VIVO Quotes by TradingView
  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email